FindTrial
Sign In

Outcome of Peritoneal Dialysis peritonitis with switch from glucose based dialysate to icodextrin.

A randomized, open label, multi-Centre study to evaluate the outcome of peritonitis with switch From glucose based dialysate to icodextrin during an episode of peritonitis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/07/002842
Enrollment
40
Registered
2012-07-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- renal failure on peritoneal dialysis

Interventions

Intervention1: Icodextrin: "During peritonitis, Ico group will be shifted from glucose based dialysate to 2 exchange of icodextrin of 12 hour duration for the study period / duration of treatment for

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Signed informed consent. 2. Men or women above 18 years of age.

Exclusion criteria

Exclusion criteria: 1. Subject with history of peritonitis within last 1 month. 2. Subject with history of hepatitis B, C or HIV. 3. Subject on immunosuppressant drugs.

Design outcomes

Primary

MeasureTime frame
â?¢ The primary outcome measure will be recovery from peritonitis, which will be compared between the two groups.Timepoint: 2-4 weeks—

Secondary

MeasureTime frame
â?¢ The secondary outcome will be comparison, between the groups, of days to normalize the fluid cell count, catheter removal, and death from peritonitis.Timepoint: 2-4 weeks—

Countries

India

Contacts

Public ContactSwati Niture

Aditya Birla Memorial Hospital

tjeloka@yahoo.com30717703

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026